Exagen Inc. announced that Jeff Elliott is joining the company’s board of directors. He currently serves as Chief Financial Officer at Exact Sciences where he leads all elements of the company’s finance function, including accounting, financial reporting, planning and analysis, internal audit, investor relations, treasury, commercial and operational data analytics, and risk management. Previously, he was the Vice President of Strategy and Business Development, where he advanced the company’s corporate strategy and efforts in developing new business partnerships to strengthen growth. Before joining Exact Sciences, Mr. Elliott was the Senior Analyst, Life Science Tools and Diagnostics at Robert W. Baird & Co., where he led company and industry research, built financial models, and issued stock recommendations to support institutional clients’ investment decisions.